Literature DB >> 24833786

IL-6 targeting compared to TNF targeting in rheumatoid arthritis: studies of olokizumab, sarilumab and sirukumab.

Yoshiya Tanaka1, Emilio Martin Mola2.   

Abstract

Entities:  

Keywords:  DMARDs (biologic); Rheumatoid Arthritis; Treatment

Mesh：

Substances：

Year:  2014        PMID： 24833786     DOI： 10.1136/annrheumdis-2013-205002

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  32 in total

Review 1.  Cholangiocarcinoma: molecular pathways and therapeutic opportunities.

Authors:  Sumera Rizvi; Mitesh J Borad; Tushar Patel; Gregory J Gores
Journal:  Semin Liver Dis       Date:  2014-11-04       Impact factor: 6.115

Review 2.  CD19-targeted chimeric antigen receptor T-cell therapy for acute lymphoblastic leukemia.

Authors:  Shannon L Maude; David T Teachey; David L Porter; Stephan A Grupp
Journal:  Blood       Date:  2015-05-21       Impact factor: 22.113

Review 3.  Emerging Therapies for Rheumatoid Arthritis.

Authors:  Joachim R Kalden
Journal:  Rheumatol Ther       Date:  2016-06-03

Review 4.  Selected cytokine pathways in rheumatoid arthritis.

Authors:  Mélissa Noack; Pierre Miossec
Journal:  Semin Immunopathol       Date:  2017-02-17       Impact factor: 9.623

Review 5.  IL-6 as a keystone cytokine in health and disease.

Authors:  Christopher A Hunter; Simon A Jones
Journal:  Nat Immunol       Date:  2015-05       Impact factor: 25.606

6.  Disentangling the effects of tocilizumab on neutrophil survival and function.

Authors:  Timo Gaber; Martin Hahne; Cindy Strehl; Paula Hoff; Yvonne Dörffel; Eugen Feist; Gerd-Rüdiger Burmester; Frank Buttgereit
Journal:  Immunol Res       Date:  2016-06       Impact factor: 2.829

7.  Cytokine neutralization at specific cellular source : A new therapeutic paradigm?

Authors:  A A Kruglov; S A Nedospasov
Journal:  Z Rheumatol       Date:  2017-03       Impact factor: 1.372

8.  [Cytokine neutralization at specific cellular source : A new therapeutic paradigm? German Version].

Authors:  A A Kruglov; S A Nedospasov
Journal:  Z Rheumatol       Date:  2017-03       Impact factor: 1.372

Review 9.  Room for more IL-6 blockade? Sarilumab for the treatment of rheumatoid arthritis.

Authors:  Rayford R June; Nancy J Olsen
Journal:  Expert Opin Biol Ther       Date:  2016-08-08       Impact factor: 4.388

Review 10.  The Therapeutic Landscape of Rheumatoid Arthritis: Current State and Future Directions.

Authors:  Shahin Shams; Joseph M Martinez; John R D Dawson; Juan Flores; Marina Gabriel; Gustavo Garcia; Amanda Guevara; Kaitlin Murray; Noah Pacifici; Maxemiliano V Vargas; Taylor Voelker; Johannes W Hell; Judith F Ashouri
Journal:  Front Pharmacol       Date:  2021-05-28       Impact factor: 5.810
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.